Research Article
Oxidative Stress and Gut-Derived Lipopolysaccharides in Neurodegenerative Disease: Role of NOX2
Table 2
Clinical and laboratory characteristics of AD, PD, and ALS patients.
| | Clinical characteristics | AD () | PD () | ALS () |
| | Age (years) | | | | | Gender (males/females) | 24/23 | 2/6 | 4/5 | | BMI | | | | | Hypertension | 35 | 4 | 7 | | Diabetes | 5 | 0 | 2 | | Dyslipidemia | 22 | 2 | 4 | | Current smoking | 0 | 1 | 0 | | Serum isoprostanes (pmol/l) | | | | | sNOX2-dp (pg/ml) | | | | | H2O2 (μM) | | | | | LPS (pg/ml) | | | | | LPS (EU/ml) | | | | | Zonulin (ng/ml) | | | | | ADL | | — | — | | IADL | | — | — |
|
|
